Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?

E-ISSN： 1996-3181|7|1|28-44

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.7, Iss.1, 2008-02, pp. : 28-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammatory Process as a Determinant Factor for the Degeneration of Substantia Nigra Dopaminergic Neurons: Possible Relevance to the Etiology of Parkinson's Disease

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 4, 2004-12 ,pp. : 223-233

Bentham Science Publishers

Access to resources Recommend Favorite

Could statins prevent age-related macular degeneration?

By Martyn Christopher N Hall Nigel F

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 803-807

Informa Healthcare

Access to resources Recommend Favorite

Theophylline-induced grooming: possible indirect dopaminergic mechanism

By Zarrindast M.-R. Sharifzadeh M. Sadeghi A.-I.

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 1-4

Elsevier

Access to resources Recommend Favorite

Bupropion induces sniffing: a possible dopaminergic mechanism

By Zarrindast M.R. Hodjati M.R. Pejhan A. Soleimannejad E.

European Neuropsychopharmacology, Vol. 6, Iss. 4, 1996-11 ,pp. : 299-303

Elsevier

Access to resources Recommend Favorite

Nitric oxide, glial cells and neuronal degeneration in parkinsonism

By Hirsch E.C. Hunot S.

Trends in Pharmacological Sciences, Vol. 21, Iss. 5, 2000-05 ,pp. : 163-165

Elsevier

Access to resources Recommend Favorite